News Focus
News Focus
Post# of 257266
Next 10
Followers 77
Posts 4790
Boards Moderated 0
Alias Born 09/06/2003

Re: TastyTheElf post# 128852

Thursday, 10/20/2011 1:37:50 AM

Thursday, October 20, 2011 1:37:50 AM

Post# of 257266

I tested positive, and know my chances of having the disease....

There is a 70% chance I have the disease, and a 30% chance that I don't.



This is incorrect and is the source error that almost everyone makes - that Test False Positive+ Test True Positive=1. Or, put another way - that Test False Positive Proportion equals Population False Population Proportion. These are both false assumptions. See Base Rate Fallacy and False Positive Paradox .

More particularly the real formula for the Risk-that-if-you-test-positive-you-really-have-the-disease is I*(1-FN)/{(1-I)*FP+(1-FN)*I}

So, why does this matter in biotech investing? Because:

1) Humans are STRONGLY predisposed to misjudge the odds when the incidence rate is lower than the false positive rate. In particular they will vastly over-estimate the odds that a positive test means they have the real thing.

2) In the case of biotech investing the incidence rate (the percent of drugs entering into ph iii that turn out to have good efficacy) is very low - and the rate of false positives is very high (almost all those drugs entering ph iii had some kind of 'positive' indicator).

3) Therefore experienced biotech investors learn, over time, that they need to hugely decrease the False Positive rate. I.e. they are much much more pessimistic than a newbie would think justified. 0.03 on a subgroup sounds great to a newbie - but still has way too high a false positive rate for an experience biotech investor.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today